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The outer membrane protein F (OmpF) is known to play an important role in the uptake of fluoroquinolone antibiotics by bacteria. In this
study, the degree of binding of the fluoroquinolone antibiotic ciprofloxacin to OmpF in a lipid membrane environment is quantified using a
methodology based on Förster resonance energy transfer (FRET). Analysis of the fluorescence quenching of OmpF is complex as each OmpF
monomer presents two tryptophans at different positions, thus sensing two different distributions of acceptors in the bilayer plane. Specific FRET
formalisms were derived accounting for the different energy transfer contributions to quenching of each type of tryptophan of OmpF, allowing the
recovery of upper and lower boundaries for the ciprofloxacin-OmpF binding constant (KB). log (KB) was found to lie in the range 3.15–3.62 or
3.58–4.00 depending on the location for the ciprofloxacin binding site assumed in the FRET modelling, closer to the centre or to the periphery of
the OmpF trimer, respectively. This methodology is suitable for the analysis of FRET data obtained with similar protein systems and can be readily
adapted to different geometries.
© 2007 Elsevier B.V. All rights reserved.Keywords: Fluorescence; Fluoroquinolones; Porin; Membrane protein; Membrane model system1. Introduction
Quinolones are broad-spectrum antibacterial agents which
mechanism of action is the inhibition of DNA gyrase and DNA
topoisomerase IV enzymes that control DNA topology and are
vital for bacterial replication [1–3]. Access to the target site is a
major determinant of antibacterial activity, with the outer
membrane being the major permeability barrier in Gram negative
bacteria [1]. In fact, one of the mechanisms of resistance
developed by the bacterial cell is the process of making more
difficult the access of quinolones to their target of action, by eitherAbbreviations: CP, Ciprofloxacin; FRET, Förster resonance energy transfer;
oPOE, n-octylpolyoxyethylene; OmpF, Outer Membrane protein F; DMPC,
Dimyristoyl-L-α-phosphatidylcholine; Trp, tryptophan; CMC, critical micellar
concentration
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doi:10.1016/j.bbamem.2007.07.016not expressing or expressing structurally changed outer mem-
brane porins [3,4]. One of those porins, which microbiology
studies related to the permeation of some quinolones through the
outer membrane, is OmpF [1,3–6]. Indeed, porin-deficient
mutants of Escherichia coli are resistant to fluoroquinolones,
although the role of OmpF, either as a channel or as an enabler of
quinolone diffusion at the OmpF/lipid interface, has not yet been
elucidated. The relative importance, and the different areas of
contact of each quinolone with OmpF, is a subject of great
importance in the context of developing new molecules with less
resistance problems.
OmpF is a trimer within the membrane and it contains just
two tryptophan residues per monomer (Fig. 1), Trp214 at the lipid
protein interface and Trp61 at the trimer interface [7]. The protein
shows a maximum of emission at relatively low wavelengths,
which suggests that both tryptophans are in hydrophobic
environments. This is confirmed by experiments involving
OmpF mutants [7], which lack one or both Trps.
Fig. 1. The structure of the OmpF trimer. The positions of the two Trp residues (Trp214 and Trp61) in each monomer are shown. Views of OmpF organization: top (A)
(8) (Reproduced by permission of Biophysical Journal) and perpendicular to membrane axis (B). Trimer interface in (B) is assigned by T. The image was draw with
PYMOL (DeLano Scientific, San Carlos, CA, http://pymol.sourceforge.net) using PDB coordinates 1OMF1 [22].
Fig. 2. Chemical structure of ciprofloxacin.
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currently under clinical use for which many resistances have
been reported in a large number of microbial species. The aim of
the present study was to investigate the role of OmpF as a major
pathway for CP entry through the outer membrane into the
bacterial cell by analyzing the alteration of OmpF fluorescence
in presence of increasing concentration of CP.
In this way, the extent of Förster resonance energy transfer
(FRET) between OmpF and CP was measured, which associated
with a rationalmodelling of the distribution of donor and acceptors
in the bilayer allowed us to quantify the extent of binding between
the protein and the antibiotic. The FRETmodelling presented here
is also suitable for application to systems with different
geometries, and the new FRET formalisms derived can be readily
adapted to the analysis of FRET data obtained with other large
membrane proteins presenting donor fluorophores in the protein–
lipid interface.
Our study assumes significance in the overall context of the
increasing problem of bacterial resistance to the antibiotics
currently in use, and the consequent need of understanding the
processes involved, in order to create new molecules with
increased antibacterial activity and less resistance problems.2. Materials and methods
Ciprofloxacin (CP) was a gift from Bayer (Leverkusen, Germany). N-(2-
hydroxyethyl) piperazine-N′-ethanesulfonic acid (HEPES) was from Sigma
(Sigma, St. Louis, MO). Octylpolyoxyethylene (oPOE) was from Bachem
(Bubendorf, Switzerland) and all other chemicals were from Merck (Darmstadt,
Germany). All solutions were prepared with 10 mM HEPES buffer (0.1 M NaCl;
pH 7.4). OmpF was purified from E. coli, strain BL21 (DE3) Omp8, following
published procedures [8]. OmpF concentration was estimated using the
bicinchoninic acid protein assay against bovine serum albumin as standard.
All the absorption measurements were carried out with a UNICAM UV-300
spectrophotometer equipped with a constant-temperature cell holder. Spectra
were recorded at 37 °C in 1 cm quartz cuvettes in the range 230 to 350 nm.
Fluorescence measurements were performed in a Varian spectrofluorimeter,
model Cary Eclipse, equipped with a constant-temperature cell holder (Peltier
Fig. 3. Normalized fluorescence emission spectra of OmpF (- - -) and absorption
spectra of ciprofloxacin (—).
Fig. 4. (A) Positions of donors (Trp61 and Trp214) and acceptors (ciprofloxacin) in th
cylinder of radius 30 Å (see text). (B) Representation of the OmpF trimer as assumed
located in the periphery of the OmpF trimer.
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stirring, with slit widths of excitation and emission of 10 nm.
3. Solutions
All the antibiotic solutions and proteoliposomes suspensions
were prepared in 10 mM HEPES buffer (pH 7.4, 0.1 M NaCl).
3.1. Reconstitution of OmpF in DMPC liposomes
As the final purpose for the proteoliposomes was the study of
the quinolones interaction with OmpF in a structural perspective,
correct orientation of protein insertion was important and best
achieved by direct incorporation of OmpF into preformed
liposomes [9–12]. Having this into consideration, OmpF
proteoliposomes were prepared by direct incorporation into
preformed DMPC liposomes, by a well-established methodology
[10,13–15]. Briefly, an adequate volume (∼2.6 ml) of DMPCe DMPC bilayer. In the simulations, the OmpF monomer is approximated to a
in the FRET simulations. Trp61 is located in the trimer interface whereas Trp214 is
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according usual procedures [16], is added to OmpF (0.45 mg) in a
HEPES buffer solution with 0.4% of oPOE. The lipid/protein
mole ratio is always near 1000 and the total volume of the mixture
assures a final concentration of oPOE lower than the value of its
CMC (0.23%). After an efficient homogenization by gentle
stirring, the mixture is incubated 15 min at room temperature
followed by 1 h on ice. The detergent is then adsorbed onto SM2
Bio-Beads® from Bio-Rad (Hercules, CA) at a concentration of
0.2 g of Bio-Beads/ml, by gently shaking of the suspension during
a period of 3 h. After this time, a second portion of the same
amount of Bio-Beads is added and the suspension is again shaken
for another 3 h. In the end of this period, proteoliposomes are
gently removed by decanting the Bio-Beads. The orientation of
OmpFby this reconstitution procedure is considered similar to that
observed in the bacterial membranes, based in experimental and
molecular dynamics studies [17,18].
As the study to be performed is based on the fluorescence of
OmpF, the presence of protein not inserted in the membrane
would lead to errors in the final results. The suspension of
proteoliposomeswas therefore submitted to an ultracentrifugation
(80,000×g, 4 °C, 2 h) in order to remove any traces of protein not
incorporated. After this procedure the supernatant was rejected
and the pellet suspended in HEPES buffer. Protein was quantified
in the liposomes and in the supernatant. The percentage of
incorporation by this methodology was always higher than 76%.
In the final step of the procedure the proteoliposomes are
sequentially extruded through 200 and 100 nm polycarbonate
membranes from Nucleopore (Kent, WA).
3.2. Quenching of OmpF fluorescence by CP
The fluorescence quenching studies were achieved by
successive additions of a constant volume (10 μl) of CP solution
(∼296 μM) to the cuvette (final concentration range: 0–38 μM)
containing a constant amount of OmpF (∼0.45 μM) incorpo-
rated in the liposomes.
Fluorescence spectra were measured with an excitation
wavelength of 290 nm. Inner filter effects and dilution of the
solution were taken into account.
4. Theoretical modelling
CP quenches OmpF fluorescence through a Förster reso-
nance energy transfer (FRET) mechanism. FRET efficiencies
(E) are calculated from the extent of fluorescence emission
quenching of the donor induced by the presence of acceptors,
E ¼ 1 IDA
ID
¼ 1
Z l
0
iDAðtÞdtZ l
0
iDðtÞdt
ð1Þ
where IDA and ID are the steady-state fluorescence intensities of
the donor in the presence and absence of acceptors respectively.
iDA(t) and iD(t) are the donor fluorescence decays in the
presence and absence of acceptors respectively. Although thereis a contribution of static quenching to FRET in OmpF–CP
complexes, Eq. (1) still holds since this is taken into account as
described below (Eqs. (8)–(12)).
As seen in Fig. 3, CP absorbance overlaps with the OmpF's
fluorescence emission spectrum (from both tryptophans 214
and 61), and the overlap integral (J) is calculated as:
J ¼
Z
f ðkÞd eðkÞd k4d dk ð2Þ
where f (λ) is the normalized emission spectrum of the donor
and ε(λ) is the absorption spectrum of the acceptor.
The Förster radius (R0) is given by:
R0 ¼ 0:2108 d ðJ d j2d n4d /DÞ1=6 ð3Þ
where the orientational factor is assumed in the dynamic isotropic
regime (κ2=2/3), the refractive index of the medium is n=1.44,
and ϕD is the donor quantum yield. The numeric factor in Eq. (3)
assumes nm units for the wavelength λ and Å units for R0.
The Förster radius (R0) of the Tryptophan(OmpF)–Ciproflax-
acin donor–acceptor pair was determined to be 23.3 Å. This is an
average value since each of the tryptophans has distinct fluores-
cence properties and therefore is expected to present different (but,
in any case, very similar, probably within 1–2 Å of each other)
Förster radii for energy transfer to CP.
Through an analysis of the extent of fluorescence quenching of
a donor by the acceptor in a FRET experiment it is possible to
calculate a binding constant (KB) between these two molecules.
However, care must be taken when working in solutions where
acceptors are highly concentrated, as it is often the case in
experiments performed on liposomes. In these cases, when both
donors and acceptors partition to the lipid bilayer and interact
there, the concentration of acceptors around the donors increases
dramatically relatively to a situation where they are both free in
solution. FRETcan be efficient at distances up to 100Å depending
on the Förster radius of the donor–acceptor pair [19] and therefore,
donors in a medium highly concentrated in acceptors, besides
being susceptible to fluorescence quenching due to formation of
specific donor–acceptor complexes, are also quenched by non-
bound, nearby acceptors. Only the first contribution is relevant for
the determination of the binding affinity of the donor–acceptor
complex, and as the two contributions are not additive (Eq. (4)),
formalisms that accurately account for the contribution of non-
bound acceptors for the experimentally measured energy transfer
efficiencies must be derived, considering the geometrical
peculiarities of the studied system. The donor fluorescence
decay in the presence of acceptors (iDA(t)) is described as:
iDAðtÞ ¼ cd iDðtÞd qboundðtÞd qnonboundðtÞ
þð1 cÞd iDðtÞd qnonboundðtÞ ð4Þ
where γ is the fraction of OmpF bound to CP, ρbound is the FRET
contribution from energy transfer to acceptors bound toOmpf, and
ρnonbound is the FRET contribution arising from energy transfer to
non-bound acceptors, randomly distributed in different planes (i)
from the donors.
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ρnonbound for a cylindrically symmetric donor geometry is
given by [20]:
qnonbound¼ji exp 2d n2d pd w
2
i d
Z wiﬃﬃﬃﬃﬃﬃﬃﬃ
w2
i
þR2e
p
0
1 expðtd bid a6Þ
a3
da
 !" #
ð5Þ
where bi=(R0
2/wi)
2τD
−1/3, n2 is the acceptor density in each
bilayer leaflet (number of acceptors per unit area), wi is theFig. 5. Representations of the OmpF trimer with possible ciprofloxacin binding
sites specified (diagonal filling) for each of chosen binding models. (A) Model I:
binding site for ciprofloxacin is located near the trimer interface. Quenching of
Trp61 is complete after antibiotic binding, while the three Trp214 are at a distance
of 30 Å from ciprofloxacin. (B) Model II: binding site for ciprofloxacin is
located in the trimer periphery near one of the Trp214 which is completely
quenched after binding. The other Trp214 are at a distance of 52 Å from the
binding site, whereas the three Trp61 are at a distance of 30 Å.distance between the plane of the donors and the i-th plane of
acceptors and Re is the donor exclusion radius (which defines
the area around the donor from where the acceptors are
excluded). In protein–ligand FRET studies the exclusion radius
is particularly important if the size of the protein is comparable
to the Förster radius of the donor–acceptor pair.
In order to calculate ρnonbound, a model must be used to
describe the positions of the donors and acceptors in the bilayer.
OmpF has two clear belts of aromatic residues at the lipid/water
interface separated by 25 Å [21]. Both Trps (61 and 214) are
located in the same aromatic belt and are assumed to be in the
same plane, at 12.5 Å from the center of the bilayer. When
incorporated in liposomes, CP is located in the headgroup region
of the bilayer [22] and according to Nagle and Tristan-Nagle [23]
for DMPC the headgroups average position is 18 Å away from
the centre of the bilayer. In the FRET simulations this is
considered to be the position of the plane of acceptors and w1
and w2 are assumed to be 5.5 Å and 30.5 Å (Fig. 4A). In our
formalismwe consider that there is no partition of non-bound CP
in the bilayer area occupied by the OmpF trimer apart from the
specifically bound population of antibiotic molecules.
Trp61 is located at the trimer interface (Fig. 4B) and the
exclusion area for non-bound CP will be significant. Re (Eq. (5))
of Trp61 is assumed to be 30 Åwhich is the approximate diameter
of an OmpF monomer in the bilayer plane [24] (Fig. 4B).
On the other hand, Trp214 is located in the periphery of the
OmpF trimer and the distribution of non-bound CP around it will
be cylindrically asymmetric. This difference in the distribution of
acceptors sensed by the two donors (Trp214 and Trp61) can only be
accounted through the use in the FRET simulations of two
different ρnonbound contributions.
For Trp61 the FRETcontribution is simply given by Eq. (5) and
setting i=2, w1=5.5 Å, w2=30.5 Å and Re=30 Å. In the case of
Trp214 a large section of the bilayer is also occupied by the protein
trimer itself and inaccessible to acceptors. However, this placement
of the protein around the tryptophan is no longer symmetrical as
for Trp61, and energy transfer must be accounted differently:
qnonbound V tð Þ¼ji expf  2pn2w2i Zwi= ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃw2i þR V2dpwi= ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃw2i þR2pp 1 exp  tsD  R0wi 6a6" #f að Þ( )da"26664

Z 1
wi=
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
w2i þR2p
p exp 
t
sD
 
R0
wi
 6
a6
" #
f að Þa3dag37775 ð6Þ
ρnonbound' is therefore the FRET contribution to the decay of a
donor located in the surface of a protein of radius RP due to the
presence of acceptors randomly distributed in i different planes
(for details on the derivation of this component and on function f
(α) see Appendix).
Using Eqs. (1) and (4)–(6), theoretical expectations for FRET
efficiencies for a randomdistribution of acceptors can be estimated.
In the simulations and data analysis of FRETefficiencies it was
considered that Trp61 and Trp214 contributed equally to the fluo-
rescence intensity of the protein. Also, energy migration among
the Trp61 does not affect the geometry of the problem, and energy
Table 1
Lower and upper limits for the binding constants of CP-OmpF for each of the CP
binding sites considered in the analysis
log(KB)(lower limit) log(KB)(upper limit)
Model I a 3.15 3.62
Model II b 3.58 4.00
a CP binding site is assumed to be in close proximity to Trp61.
b CP binding site is assumed to be close to the periphery of the trimer, near
Trp214.
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due to the distance (30 Å) between the two residues.
4.2. Contribution to FRET of specifically bound acceptors
To quantify the contribution of specifically bound CP to
FRET, it is first necessary to relate the binding constant of this
antibiotic and OmpF (KB) to the factor γ (fraction of OmpF
bound to CP) in Eq. (4):
c ¼ 1þ ½OmpFd KB þ ½CPd KBð Þ þﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
ð1þ ½OmpFd KBþ ½CPd KBÞ2  4d K2Bd ½OmpFd ½CP
q
2
64
3
75 = 2d KBd ½OmpFTotal
ð7Þ
where [OmpF]Total and [OmpF] are the total and unbound
concentrations of OmpF, and [CP] is the concentration ofFig. 6. Extent of energy transfer (Eq. (1)) for the OmpF tryptophan-
Ciprofloxacin, donor acceptor FRET pair. Simulation for absence of binding
(random distribution of acceptors) (Eqs. (4)–(6)) (·-·-·). (A) A model assuming
binding of ciprofloxacin near the trimer interface (Model I) was fitted to the
experimental data (Eqs. (4)–(12)). The interval of 3.15b log(KB)b3.62 was
recovered for the binding constant (grey area). (B) A model assuming binding of
ciprofloxacin to the OmpF periphery (Model II) was fitted to the experimental
data. The interval of 3.58b log(KB)b4.00 was recovered for the binding
constant (grey area). The simulations for the upper and lower bounds of KB are
represented in both figures by a solid line (—) and by a dotted line (·····),
respectively.unbound CP. It is assumed that only 1:1 complexes can be
formed between OmpF and CP. The 1:1 complex model is
supported by data from a previous study [25].
In the event of binding of CP to Ompf, the fluorescence of the
several Trps present in one trimer will be quenched differently,
as the distances between them and the antibiotic will be also
different. Therefore, also for ρbound, two different contributions
for Trp214 and Trp61 must be considered.
qbound ¼ qboundðTrp214Þ þ qboundðTrp61Þ ð8Þ
Assuming that at least one of the tryptophans of OmpF is part
of a hypothetical CP binding site and subsequently completely
quenched, and that no more than one antibiotic molecule can be
specifically bound to a OmpF trimer at a given time, two models
were devised: (i) the CP binding site is close to the center of the
trimer and binding of antibiotic leads to complete quenching of
the three Trp61 (distance of Trp61 to CP≪ R0) (Fig. 5A); (ii) the
binding site is near the protein–lipid interface (Fig. 5B). In the
first case (Model I), it is assumed that only the three Trp214
residues remain fluorescent (ρIbound(Trp61)=0) and the CP binding
site is located at 30 Å (d1, trimer radius) from them. The
contribution to FRET of specifically bound CP is given by:
qIboundðTotalÞ tð Þ ¼ qIboundðTrp214Þ tð Þ ¼ exp 
t
sD
d
R0
d1
 6 !
ð9Þ
where τD is the average donor lifetime.
In the case of binding of CP near the surface of the OmpF
trimer (Model II) with complete quenching of one Trp214, the
antibioticmolecules will be located at a distance of 30Å (d1′) from
Trp61 (the centre of mass of the three Trp61 is located in the centre
of the trimer) and 52 Å (d2) from the other two Trp
214. As a result,
ρIIbound (Trp214) is multiplied by 2/3 and the contributions to FRET
of specifically bound CP are given by:
qIIboundðTotalÞ ¼ qIIboundðTrp61Þ tð Þ þ
2
3
d qIIboundðTrp214Þ tð Þ ð10Þ
qIIboundðTrp61Þ tð Þ ¼ exp 
t
sD
d
R0
d1 V
 6 !
ð11Þ
qIIboundðTrp214Þ tð Þ ¼ exp 
t
sD
d
R0
d2
 6 !
ð12Þ
Fig. A1. Schematic side (A) and top (B) views of a lipid bilayer containing a
cylindrical membrane protein labelled with a donor fluorophore (D) at its outer
radius, capable of FRET to acceptors (A) located in the lipid bilayer, on a plane
parallel to the bilayer plane. See text for details.
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Successive additions of small volumes of a CP solution to
OmpF proteoliposomes resulted as expected in a decrease of
fluorescence fromOmpF (Fig. 6). Using Eqs. (4)–(6) it is possible
to compare the theoretical expectation for the efficiencies of
energy transfer from the tryptophans of OmpF to unbound CP
(randomly distributed) with the data obtained experimentally.
Clearly the extent of quenching of the tryptophans cannot be
exclusively explained on the basis of energy transfer to unbound
CP, and a FRET contribution to specifically associated antibiotic
must be considered.
The binding constants that allow for better fits to the data
points are different depending on the model for binding that is
considered (I or II). In the case of model I, that assumes binding
of CP close to the centre of the trimer, quenching is much more
effective as the binding site is in the vicinity of three tryptophans
(Trp61), while for model II only one tryptophan is located near
the bound antibiotic. This results in the recovery of larger KB
values for model II than for model I. Upper and lower limits for
KB (that allow respectively for better fits to the data points
corresponding to the lower and higher CP concentration ranges)
were determined for each model, and are shown in Table 1.
In a previous study, changes in CP absorption spectra were
used to estimate a OmpF-CP binding constant and values of log
(KB)=3.85±0.34 or 4.17±0.03 were obtained depending on the
method chosen to analyze the absorption spectra changes after
addition of OmpF in a micellar environment [25]. These values
fall within or close to the range of KB obtained by us from the
energy transfer data assuming binding of CP to the periphery of
OmpF (3.58bKBb4.00). This agreement with an alternative
method can be seen as an indication that the antibiotic binding
site is likely to be located away from the centre of the OmpF
trimer where FRETwould be more efficient and imply a smaller
KB.
6. Conclusions
In the present study, the CP fluoroquinolone is shown to
associate with OmpF using FRET methodologies. The high
symmetry of the OmpF trimer allowed the analysis of FRET data
with formalisms that accounted for the different distributions of
acceptors around the two types of tryptophans present in the
protein. This methodology is suitable for application in the
analysis of FRET data obtained with similar protein systems and
can be adapted to different geometries. The newFRET formalisms
presented here for a donor in the surface of a cylinder of large
radius (with radius comparable to the Förster radius) are expected
to be of great assistance in the analysis of FRET data obtainedwith
membrane proteins presenting donor fluorophores in the protein–
lipid interface.
The equilibrium constant retrieved for the association event
between OmpF and CP assuming binding of the antibiotic in the
periphery of the porin is in agreement with a value determined
previously by an independent method (in a micellar environ-
ment), indicating that the binding site of the antibiotic is likely
to be located away from the center of OmpF. Also, the FRETmethodology can be applied in cases where there are no spectral
shifts, and its sensitivity is higher as compared to absorption
methodologies.
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Appendix A. Derivation of the FRETrate between a donor at
the outer radius of a cylindrical transmembrane protein to a
plane of acceptors distributed around the latter
Fig. A1 shows the geometry relevant to this problem. Our
derivation of the FRET rate law begins with the general
expression for the average decay for a donor located in the centre
of a finite disk with radius Rd, bρ(t)NN , taking into account all
statistical arrangements of the N acceptor molecules located
inside the disk [26]:
bq tð ÞNN ¼ exp t=sð Þdj
N
i¼1
Z ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃw2þR2dp
w
exp  t
s
R0
Ri
 6" #
W Rið ÞdRi
ðA1Þ
where W(Ri)dRi is the probability of finding acceptor molecule
Ai in the ring of inner radius Ri and outer radius Ri+dRi. The
acceptor distribution function is normalized, in the sense that
Z ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃw2þR2dp
w
W ðRiÞdRi ¼ 1 ðA2Þ
We now proceed as previously done by Davenport et al. [20]
and Capeta et al. [27] for similar (albeit simpler) geometries.
Because all acceptors have the same distribution function, W(Ri)
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identical, and denoting them by J(t), we can write
bq tð ÞNN ¼ exp  tsD
 
d ½JðtÞN ðA3Þ
As pointed out by Davenport et al. [20], the probability of
finding an acceptor at a distance between R and R+dR to the
donor in question, given by W(R)dR, is equal to that of finding
an acceptor in the ring between R′ and R′+dR′ in the acceptors
plane, given byW(R′)dR′. The acceptor distribution function, in
terms of R′=Rsinθ (see Fig. A1A), is given by
W R Vð Þ ¼
½1þ ð2=pÞarcsinðR V=2RpÞR V
R V2d  R2p
0bR Vb2Rp
2R V
R V2d  R2p
2RpbR VbR Vd
8>><
>>:
ðA4Þ
Note that, whereas for R′N2Rp (where Rp is the cylindrical
protein radius)W(R′) is as expected for a uniform distribution of
acceptors in a planar disk (only corrected in the denominator for
the excluded area resulting from the existence of a protein
molecule inside Rd), for R′b2Rp the more complex expression
denotes that only a fraction of the region between R′ and R′+dR
is available to acceptors (the shaded area in Fig.A1B). Insertion of
this distribution function in the definition of J(t) (the integral in
Eq. (A1)), together with the substitution α=cosθ=w/R, leads to
J tð Þ ¼ 2w
2
R V2d  R2p
Z 1
w=
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
w2þR V2d
p exp 
t
sD
 
R0
w
 6
a6
" #
fðaÞa3da
ðA5Þ
where
f að Þ ¼
1
wﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
w2 þ R V2d
q bab wﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
w2 þ 4R2p
q
1
2
þ 1
p
arcsin
w
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1 a2
p
2aRp
 !
wﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
w2 þ 4R2p
q bab1
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We now rearrange Eq. (A5) into
J tð Þ ¼ 2w
2
R V2d  R2p
Z w= ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃw2þR2pp
w=
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
w2þR V2d
p a3da
Z w= ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃw2þR2pp
w=
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
w2þR V2d
p 1 exp 
t
sD
 
R0
w
 6
a6
" #
f að Þ
( )
da
 
þ
Z 1
w=
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
w2þR2p
p exp 
t
sD
 
R0
w
 6
a6
" #
f að Þa3da
!
ðA7Þand denote the integrals on the right hand side of Eq. (A7) by J1,
J2(t) and J3(t), according to the order in which they appear in
this equation. J1 is easily calculated, leading to
J tð Þ ¼ 1 2w
2
R V2d  R2p
J2 tð Þ  J3 tð Þ½  ðA8Þ
Being the average concentration of acceptors in the bilayer
given by,
n2 ¼ NpðR V2d  R2pÞ
ðA9Þ
it follows that
J tð Þ ¼ 1 2pn2w
2
N
J2 tð Þ  J3 tð Þ½  ðA10Þ
Inserting this expression for J(t) in Eq. (A1), and taking the
limit (N→∞, R′d→∞), one obtains the macroscopic decay law.
The result is,
qðtÞ ¼ expf2pn2w2½J2ðtÞ  J3ðtÞg ðA11Þ
which is equivalent to each of the i items in the product of the
right hand side of Eq. (6).
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